JOHN JOHNSON - Director at Xeris Biopharma Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
XERS on Nasdaq
All Insider Reports
All Insider Reports

JOHN JOHNSON - trading volume in the past year for Xeris Biopharma Holdings, Inc.

Holdings reported by JOHN JOHNSON for Xeris Biopharma Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 698,083 $5,037,227 $7.22 19 Dec 2025 Direct

Transactions reported by JOHN JOHNSON for Xeris Biopharma Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.